Dr Panteli Theocharous

Biography
Dr Panteli Theocharous, PhD, FRCPath, is a globally recognised cell and gene therapy executive, translational scientist and biotechnology entrepreneur with more than 35-years of experience advancing complex therapies from scientific concept through clinical development and commercialisation. He serves as Chief Therapeutics & Clinical Strategy Officer and President of Europe at Worldwide Clinical Trials, CEO of VectorGen, where he leads the development of next-generation lentiviral vector platforms, and Chairman of the Board of TMOIF. His career spans stem cell transplantation, pioneering CAR-T development, autologous and allogeneic cell therapies, gene therapy and regenerative medicine. He previously established and chaired the Cell & Gene Therapy Institute at PPD and has held senior leadership roles across advanced-therapy biotechnology companies. Dr Theocharous brings an integrated perspective across clinical development, regulatory strategy, CMC, manufacturing, biotechnology financing and commercialisation, focused on overcoming the barriers that determine whether transformative cell and gene therapies successfully reach patients.